Malaria prevention pills for school children
Treatments studied
Part of Infections clinical trials.
This trial tests giving school-age children a short course of medicine to prevent malaria and see if it can reduce the spread of the disease in the community. It involves taking pills at set times during the school year.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must currently attend a school that is part of this study.
- You (the parent or guardian) must agree in writing that your child can take part.
- If your child is between 8 and 17 years old, they must also agree to participate (this is called 'assent').
- Your child cannot have missed three days of school in a row during the study survey period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a special device that releases a scent to repel mosquitoes, aiming to reduce malaria in young children in Uganda. If you have a child under 5 and are willing to use the device in your home, this study could help protect your child from malaria.
This study aims to find the best way to treat or prevent malaria in children with HIV. It may also help children without HIV who live in areas where malaria is common.
This trial tests a mosquito repellent that is placed in homes to see if it helps prevent malaria. It is for children living in the area.
This Phase 3 trial tests whether giving malaria medicine to people in high-risk households (a “mass drug administration” campaign) can stop local relapses and eliminate vivax malaria. If you live close to a recent malaria case, you may be offered a preventive dose, based on age and medical safety checks.
This trial tests a combination of three malaria medicines in healthy volunteers to see how safe they are and how the body processes them. If you are a healthy non-smoker, you may be able to help researchers understand these drugs better.
This trial studies how artesunate works in infants under 2 years old being treated for severe malaria. It aims to learn more about the medicine to help improve treatment for babies.
Hear when a new Malaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.